Global Anticoagulation Therapy Market Analysis: Industry Trends, Size, Overview, Research Report, Share, Market Segmentation, & Forecast 2017-2025

Global Anticoagulation Therapy Market 2017-2025

Market Overview

Novel Oral Anticoagulants (NOACs) have major pharmacologic benefits over warfarin, which is a vitamin K antagonist, together with the rapid onset/offset of action, few drug interactions and predictable pharmacokinetics. Warfarin has a limited therapeutic window that can be strike by factors such as diet and enabling patients on warfarin to monitor their INR regularly. The Anticoagulation Therapy market is expected to reach USD 31.4 billion by 2025, growing at a CAGR of 8.01% during the forecast period. Novel oral anticoagulant (NOACs) is the top performing segment as an alternative to anticoagulant. Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, arrhythmia, and stroke, acceptance of NOAC’s is raising revenue in the market, rising outpatient anticoagulation therapy, increasing number of pipeline products under clinical trials and rising heparin trade spurring the growth of anticoagulation therapy market. However, high cost of developing drugs and risk of malfunctions like increased bleeding is main issue with newer agents are expected to impact the target market negatively.

Global Anticoagulation Therapy Market Segmentation

By Product Type

• Drugs
  • Novel Oral Anticoagulants (NOACs)
  • Warfarin (VKA)
  • Other Drugs
• PT/INR Testing Devices
  • In-Office Testing Devices
  • Analyzers
  • Aeagents and Kits
  • Home Testing Devices
• Service
  • Testing Services
  • Consulting Services

The NOACs segment led the anticoagulation therapy market for drugs in 2017 owing to emergence of many pharma companies to develop more secure and structured NOAC’s in future years. The in-office testing devices dominated the market for PT/INR testing devices in 2017, while home testing devices is the fastest growing segment at a CAGR of 7.88% among the PT/INR testing devices. On the basis of services, the testing services held the largest market share of the anticoagulation therapy market for clinics in 2017, on the account of cost effectiveness and instant result generation saving time.

By Clinic

• Hospital Associated Clinic
• Independent Clinics
• Pharmacy-based Clinics

By Geography

• North America (US, Canada) {Market Share (%), Market Size (USD Billion)} Anticoagulation Therapy Market
• Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion)} Anticoagulation Therapy Market
• Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion)} Anticoagulation Therapy Market
• Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion)} Anticoagulation Therapy Market
• Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion)} Anticoagulation Therapy Market
• Rest of the World {Market Share (%), Market Size (USD Billion))} Anticoagulation Therapy Market

On the basis of region, North America accounted for the largest market share of anticoagulation therapy market owing to rising number of the hospital associated clinics and high healthcare expenditure. Europe is expected to grow at the higher rate and generate quite the substantial amount of revenue owing to rising incidence of venous thromboembolism, atrial fibrillation, and stroke. On the other hand, APAC is the fastest growing region, registering the CAGR of 8.1% over the forecast period due to long-term administration and high volume of recurring sales of anticoagulation drugs for long lasting medical aid therapy.

Anticoagulation Therapy Market Trends, Demand, & Challenges              

The report covers the present ground scenario and the future growth prospects of the facility management market for 2017-2025 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players worldwide. Anticoagulation Therapy market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.

Global Anticoagulation Therapy Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the Anticoagulation Therapy market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “Global Anticoagulation Therapy Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

Our Global Anticoagulation Therapy Market Report comprises of the following companies as the key players: C. H. Boehringer Sohn, Bristol-Myers Squibb, Johnson & Johnson, Pfizer, Daiichi Sankyo, Portola Pharmaceuticals, Roche, Abbott, Siemens, Alere and CoaguSense.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Global Anticoagulation Therapy Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Anticoagulation Therapy Market
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the Healthcare industry’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects
• Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
• Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Anticoagulation Therapy market
• Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
• To strategically profile key players and comprehensively analyze their market shares and core competencies